key: cord-0844977-wmhvyu2r authors: Ryan, Charles; Minc, Alexa; Caceres, Juan; Balsalobre, Alexandra; Dixit, Achal; Ng, Becky; Schmitzberger, Florian; Syed-Abdul, Shabbir; Fung, Christopher title: Predicting severe outcomes in Covid-19 related illness using only patient demographics, comorbidities and symptoms date: 2020-09-09 journal: Am J Emerg Med DOI: 10.1016/j.ajem.2020.09.017 sha: 0facb4c1dcb3197e28e056abd016c88277d4ef0c doc_id: 844977 cord_uid: wmhvyu2r OBJECTIVE: Development of a risk-stratification model to predict severe Covid-19 related illness, using only presenting symptoms, comorbidities and demographic data. MATERIALS AND METHODS: We performed a case-control study with cases being those with severe disease, defined as ICU admission, mechanical ventilation, death or discharge to hospice, and controls being those with non-severe disease. Predictor variables included patient demographics, symptoms and past medical history. Participants were 556 patients with laboratory confirmed Covid-19 and were included consecutively after presenting to the emergency department at a tertiary care center from March 1, 2020 to April 21, 2020 RESULTS: Most common symptoms included cough (82%), dyspnea (75%), and fever/chills (77%), with 96% reporting at least one of these. Multivariable logistic regression analysis found that increasing age (adjusted odds ratio [OR], 1.05; 95% confidence interval [CI], 1.03–1.06), dyspnea (OR, 2.56; 95% CI: 1.51–4.33), male sex (OR, 1.70; 95% CI: 1.10–2.64), immunocompromised status (OR, 2.22; 95% CI: 1.17–4.16) and CKD (OR, 1.76; 95% CI: 1.01–3.06) were significant predictors of severe Covid-19 infection. Hyperlipidemia was found to be negatively associated with severe disease (OR, 0.54; 95% CI: 0.33–0.90). A predictive equation based on these variables demonstrated fair ability to discriminate severe vs non-severe outcomes using only this historical information (AUC: 0.76). CONCLUSIONS: Severe Covid-19 illness can be predicted using data that could be obtained from a remote screening. With validation, this model could possibly be used for remote triage to prioritize evaluation based on susceptibility to severe disease while avoiding unnecessary waiting room exposure. Since early reports of an unexplained pneumonia in Wuhan, China in December 2019, SARS-CoV-2 has spread to more than 200 countries and has become a global pandemic. There have been more than 24 million confirmed cases of Covid-19 as of August 28th, 2020 with over 800,000 case fatalities in 188 nations 1 . Currently, there are more than fifty thousand new cases of Covid-19 reported daily during July encounters between susceptible and infected individuals and the fidelity of transmission with each interaction. 7 Given that most patients presenting with symptoms concerning for Covid-19 infection have ultimately been negative, 8 there is a concern that a large number of uninfected individuals may come into contact with infected patients at testing centers or emergency departments and thus propagate the infection due to the contagious nature of the virus. 9, 10 There is also potential for transmission without direct contact. Viral particles have been shown to persist on surfaces for several days and new evidence suggests that aerosolized particles can be detected up to 29 feet from the infected individual and linger in the environment and may have contributed to superspreading events 11, 12, 13 . Crowded hospitals and clinics may therefore present ideal conditions for viral transmission. As such, minimizing crowding in hospital waiting areas and clinics is critical to mitigate nosocomial spread. Remote triage tools have the potential to facilitate this by evaluating patients without physical contact. Existing web-based triage tools employ branched logic questions based on early recommendations from the CDC 14 and preliminary data from China 15, 16 to advise patients, but lack statistical validation. [17] [18] [19] More recently, statistical models have been developed to predict potential Covid-19 infections, which represents an innovative step forward. However, these models either necessitate in-person collection of vital signs, imaging, and/or laboratory studies in order to risk stratify patients [20] [21] [22] [23] or do not predict disease severity and therefore do not determine which patients should be evaluated most urgently 24 For patients with multiple presentations, the encounter concluding with the highest level of care (ICU admission/mechanical ventilation) was selected for determination of the primary outcome ( Figure 1 ). Cases were those with severe illness, defined as admission to the intensive care unit (ICU), requirement for mechanical ventilation, in-hospital death, or discharge to hospice at any point during hospital admission. Controls were those with non-severe outcomes, defined as either admission to the hospital without the aforementioned outcomes or discharge from the ED without hospital admission. J o u r n a l P r e -p r o o f Definitions for all collected predictor variables may be found in Supplemental Table 1 . Primary endpoints of severe and non-severe disease are defined above. Patient data was obtained using the Electronic Medical Record Search Engine (EMERSE) 25 data retrieval tool from the electronic medical record (EMR; Epic Systems, Madison, WI). Symptoms documented by a clinician in the ED H&P, admission H&P, progress/transfer notes, or triage documentation were included if the documentation was describing symptoms at the time of initial presentation. Absence of documentation of and specific denial of symptoms (negative symptoms) were considered equal. Comorbidities, medications, and smoking status for each patient were gathered from the patient's history. If these data were not documented by clinicians during the encounter related to Covid-19, thorough inspection of the remainder of the patient's chart and external records was conducted to obtain said information. Ten patients were found to have no smoking status listed in their EMR and were treated as non-smokers in our analysis due to relatively low prevalence of smoking. Primary endpoints, assorting patients into cases and controls based on presence or absence of severe disease, were collected on May 16, 2020. Data collection was completed with consensus between two senior medical students at time of entry into a spreadsheet instrument. Variables were defined prior to data acquisition (Supplemental Table 1 ). J o u r n a l P r e -p r o o f We attempted to eliminate bias by utilizing consecutive sampling by including all Covid-19 positive patients presenting to the ED to avoid gathering a skewed sample relative to our hospital's population while increasing statistical power. Our study population of 556 patients was determined by including all Covid-19 positive patients presenting through the ED at our institution within the study date range. During the study period, a total of 7238 adult emergency patient encounters occurred and of these, 2082 encounters were screened for inclusion ( Figure 1 ) because they had received Covid-19 laboratory testing. We used descriptive statistics to characterize our full patient population as well as severe and non-severe cohorts. Univariate analysis and chi-squared tests were performed on all collected variables, and pvalues represent the result of Chi-square analysis with continuity correction. We performed continuity correction to prevent Type-1 error caused by assuming a chi-square distribution on data with small event occurrence. We fitted a multivariable logistic regression model with severe outcomes as dependent variables and patient characteristics as independent variables. To determine variables for inclusion in logistic regression analyses we first selected 25 variables, each with at least 40 event occurrences, that were the most clinically relevant for predicting severe disease based on previous reports 15, 26 . These variables J o u r n a l P r e -p r o o f Journal Pre-proof included age (in years), sex, dyspnea, cough, sputum production, fevers/chills, vomiting, diarrhea, anorexia, dizziness/syncope, immunocompromised status, obesity, obstructive sleep apnea (OSA), asthma, chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF)/cardiomyopathy, coronary artery disease (CAD)/myocardial infarction (MI), diabetes mellitus (DM), chronic kidney disease (CDK), hypertension (HTN), hyperlipidemia (HLD), smoking history and home medications of ACE-inhibitors, angiotensin receptor blockers (ARBs) or blood thinners. These 25 variables were then subjected to categorical regression with LASSO elimination, and the top 15 contributing variables were subsequently run in a binary logistic regression ( Table 2 ). The resulting odds ratios and p-values from logistic regression analysis were used to form the final predictive equation. Variables with p < 0.05 were included in the final predictive equation. We applied our predictive equation to our cohort to generate probabilities of severe disease for each patient and generated a receiver operating characteristic (ROC) curve to assess the discriminative ability of this model ( Figure 2 ). All analyses were conducted using SPSS v26 (IBM Corp. Released 2017. IBM SPSS Statistics for Windows, Version 25.0. Armonk, NY: IBM Corp). This study was approved by the Institutional Review Board. All 556 patients presenting during the study date range meeting our criteria for Covid-19 positive status were included throughout all aspects of our study. Upon conclusion of data acquisition on 05/16/2020, there were 17 patients who were still admitted to the hospital. However, 16/17 of these patients had J o u r n a l P r e -p r o o f Journal Pre-proof already met our criteria for the primary endpoint. 113/556 (20.3%) patients tested positive for Covid-19 on a health system encounter other than the index ED encounter that was studied. Of the 556 patients included in the study, 371 (66.7%) were admitted from their ED encounter and 164 (29.4%) experienced the study outcome of severe illness. A total of 146 (26.2%) patients were transferred to the ICU during their hospital stay. Eighty-three (15.2%) patients in total required mechanical ventilation. Forty-six (8.4%) died during the hospital stay or were discharged to hospice. The mean age of the study population was 57±17 years (range, 21-95). A total of 296 (53%) were male. Our cohort consisted of 225 (40%) self-identifying as White and 245 (44%) as Black (Table 1) . Symptoms most commonly reported by Covid-19-positive patients were cough (82%), dyspnea (75%), and fever or chills (77%). In total, 536 (96%) experienced one or more of these symptoms. Patients with severe outcomes were found to have a higher mean age than those with non-severe outcomes (66 vs 53 years) and were more likely to be male (63% vs 49%). Those with severe outcomes were additionally more likely to have comorbid illnesses. This was especially true with regard to chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), obstructive sleep apnea (OSA), heart failure/cardiomyopathy, cardiovascular disease, cerebrovascular disease, history of seizure, hypertension, diabetes mellitus (DM), immunocompromised status, active malignancy, chronic kidney J o u r n a l P r e -p r o o f disease (CKD), and dementia. Patients with severe outcomes were also more likely to have ACE inhibitors (ACE-Is) on their home medication list (Table 1) . Current or former smokers were also at increased risk. There were also prominent differences in the symptoms reported by patients with severe versus non-severe outcomes, with dyspnea being most significantly associated with severe outcomes. ( Table 1 ). Significant predictors associated with severe outcomes included increasing age (adjusted odds ratio Age, male sex, dyspnea, immunocompromised status, and chronic kidney disease were found to be the strongest predictors of disease severity, and hyperlipidemia was found to be a protective factor. Consistent with previous reports, advanced age was found to be the most significant predictor of severe outcomes 27 . Male sex has also been previously reported as a risk factor for poor outcomes in Covid-19 patients 28 infection among whites which is discordant with other reports 33 . This is likely explained by the significant differences in mean age between white (mean 60, SD 18) and non-white (mean 55, SD 17) patients in our cohort (p = 0.006). Here, we demonstrate a novel approach to predict a patient's risk of severe disease from Covid-19 infection based exclusively on information that can be collected remotely. We focused on predicting J o u r n a l P r e -p r o o f Our predictive model was also designed to minimize overfitting by carefully selecting candidate variables of high clinical relevance and sufficient event occurrence as recommended by Babyak et al. 34 Use of automatic selection methods with a large number of clinically insignificant variables with low event frequency, as described in previous predictive models, results in high risk of overfitting results and may lead to misleading prognostications. 20 In addition, other models excluded patients who failed to experience the primary outcome by the end of the study period, potentially introducing systematic bias 35 . As countries transition to a more liberal testing policy amid efforts to safely reopen their economies, another potential use for our model is to prioritize patients in need of testing, allocating supplies to those with a predisposition to poor outcomes. Currently, criteria for testing is highly varied, unstandardized, J o u r n a l P r e -p r o o f and rapidly evolving, as availability of testing supplies fluctuates. 36 A predictive model that prioritizes high-risk patients may allow for more appropriate allocation of resources. While this proof-of-concept study does not have the sample size or regional and institutional diversity to justify changes to management recommendations, we believe that there is value in utilizing larger emerging datasets to generate more robust predictive models based on variables that may be collected remotely. For example, the VIRUS study from the Society of Critical Care Medicine has collected many of the same variables as in our study on a larger scale 37 . A multivariable model based on these larger datasets may have sufficient validation to change clinical decision making and improve our approach to remote risk-stratification. Furthermore, in EMR systems where presenting symptoms and past medical history are reliability recorded as structured data, validation of our model or similar model may be performed rapidly. Limitations of our study include small sample size, which increases the potential for type-II error. Owing to insufficient event occurrence, conditions of clinical interest such as interstitial lung disease and neuromuscular disease could not be included in our model but likely possess prognostic utility. Our study also has the limitations of a single institution retrospective study. As there were 17 patients who were still in the hospital at the end of our data collection period, our mortality and mechanical ventilation numbers may be underestimated. Due to the nature of retrospective chart-review, symptom data has the potential for bias based on history taking and documentation. We found that critically ill patients tended to have less thorough histories and reviews of systems. In addition, history taking may have been limited in patients with altered mental status or dementia. To gather the most accurate representation of each patient's presentation, we took a composite of multiple provider notes, which may represent a level of information that would be difficult to ascertain remotely during a brief phone or electronic interaction. Furthermore, although our chart review process utilized two senior medical students, we did not perform double data entry and thus were unable to assess interrater reliability. However, this is partially mitigated by the fact that only the presence of symptoms and past medical history were determined by chart review. Outcomes were extracted from the EMR by automated methods. While our study used a differential follow up time to assess the primary outcome, only 1/164 patients meeting the primary outcome did so after our minimum follow up time of 21 days. This patient died on hospital day 24. Finally, our cohort was obtained during the first Covid-19 surge with peak prevalence within the region. It is possible that, as we reach a lower prevalence steady state, the threshold for patients to reach outcomes such as ICU admission will differ. Finally, as a tertiary care center in which complex patients present for care, our data may have reduced generalizability. Our cohort had higher rates of ICU admission than previous reports from New York, though we had similar rates of mechanical ventilation 38 . Thus, rates of and indications for ICU level care may differ by patient population and institution, limiting generalizability. To overcome these limitations, we encourage the application of larger multi-institutional datasets to develop predictive models based on the general workflow we have presented here. J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f b Includes ICU admission, ventilator status, death during hospitalization, or discharge to hospice due to Covid-19. c Includes patients who did not belong to in any of the above categories or patients with an unknown race. Abbreviations: ICU, intensive care unit; COPD, chronic obstructive pulmonary disease; ACE, angiotensin converting enzyme. a Includes patients with a history of coronary artery disease or a history of myocardial infarction. Johns Hopkins Coronavirus Resource Center An interactive web-based dashboard to track COVID-19 in real time The end of social confinement and COVID-19 re-emergence risk Risk of a second wave of Covid-19 infections: using artificial intelligence to investigate stringency of physical distancing policies in North America Geographic Differences in COVID-19 Cases, Deaths, and Incidence -United States Johns Hopkins Coronavirus Resource Center Mathematical modeling of the spread of the coronavirus disease 2019 (COVID-19) taking into account the undetected infections. The case of China The reproductive number of COVID-19 is higher compared to SARS coronavirus Minimum Infective Dose of the Major Human Respiratory and Enteric Viruses Transmitted Through Food and the Environment Social distancing for covid-19: is 2 metres far enough? Airborne transmission of severe acute respiratory syndrome coronavirus-2 to healthcare workers: a narrative review Human Coronavirus 229E Remains Infectious on Common Touch Surface Materials Evaluating and Testing Persons for Coronavirus Disease 2019 (COVID-19) Clinical Characteristics of Patients Who Died of Coronavirus Disease 2019 in China Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series National Center for Immunization and Respiratory Diseases (NCIRD) DoVD. Coronavirus Self-Checker. Center for Disease Control and Prevention. Center for Disease Control and Prevention Rapid Design and Implementation of an Integrated Patient Self-Triage and Self-Scheduling Tool for COVID-19 Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19 A Tool to Early Predict Severe 2019-Novel Coronavirus Pneumonia (COVID-19) : A Multicenter Study Using the Risk Nomogram in Wuhan and Guangdong, China. Public and Global Health Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan A Machine Learning-Based Model for Survival Prediction in Patients with Severe COVID-19 Infection Real-time tracking of self-reported symptoms to predict potential COVID-19 Supporting information retrieval from electronic health records: A report of University of Michigan's nine-year experience in developing and using the Electronic Medical Record Search Engine (EMERSE) Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US COVID-19 in Immunocompromised Hosts: What We Know So Far. Clinical Infectious Diseases Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection Statins: Could an old friend help the fight against COVID-19? Cholesterol in Relation to COVID-19: Should We Care about It? COVID-19 and Racial/Ethnic Disparities What You See May Not Be What You Get: A Brief, Nontechnical Introduction to Overfitting in Regression-Type Models Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal The Impact of Changes in Diagnostic Testing Practices on Estimates of COVID-19 Transmission in the United States The Viral Infection and Respiratory Illness Universal Study (VIRUS): An International Registry of Coronavirus